Relevium Technologies (RLV) Stock Price, News & Analysis

Company Overview

Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.

Key Stats

• Today's Range: C$0.02 to C$0.02
• 50-Day Range: C$0.02 to C$0.02
• 52-Week Range: C$0.01 to C$0.05
• Volume: 130,500 shs
• Average Volume: 140,861 shs
• Market Capitalization: C$6.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RLV Stock Analysis - Frequently Asked Questions

How have RLV shares performed this year?

Relevium Technologies' stock was trading at C$0.02 on January 1st, 2025. Since then, RLV stock has increased by 0.0% and is now trading at C$0.02.

How do I buy shares of Relevium Technologies?

Shares of RLV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Relevium Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Relevium Technologies investors own include C-Com Satellite Systems (CMI), Facedrive (FDVRF), Focus Graphite (FMS), Kraken Robotics (PNG), Quisitive Technology Solutions (QUISF), Spero Therapeutics (SPRO) and Tinkerine Studios (TTD).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: CVE:RLV
• CIK: N/A
• Web: www.releviumcorp.com
• Phone: +1-514-8248559
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$2.64 million
• Net Margins: -18.50%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: 4.20%

Debt

• Debt-to-Equity Ratio: 8,068.50
• Current Ratio: 0.60
• Quick Ratio: 0.02

Sales & Book Value

• Annual Sales: C$14.25 million
• Price / Sales: 0.46
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 20.00
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 329,490,000
• Free Float: N/A
• Market Cap: C$6.59 million
• Optionable: Not Optionable
• Beta: 1.88